StockSelector.com
  Research, Select, & Monitor Tuesday, September 26, 2017 8:46:07 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Bristol-Myers Squibb Co.$63.19($.17)(.27%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Bristol-Myers Squibb Co. has an overall rank of 2636 out of 7052 stocks based on 14 positive rankings and 10 negative rankings.

Positive Rankings
Highest ROA
Bristol-Myers Squibb Co. rank is 320
Highest ROE
Bristol-Myers Squibb Co. rank is 400
Top Intrinsic Values
Bristol-Myers Squibb Co. rank is 402
Highest Net Margin
Bristol-Myers Squibb Co. rank is 532
PEGValue
Bristol-Myers Squibb Co. has a PEG Value of $70.12. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 10.97% in the next year. Among companies with a PEG Value above the current stock price, Bristol-Myers Squibb Co. is ranked 544.
SSValue
The StockSelector Value for Bristol-Myers Squibb Co. is $88.84. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Bristol-Myers Squibb Co. is ranked 774.
90 Day Gain
Bristol-Myers Squibb Co. rank is 952
Low Put/Call
Bristol-Myers Squibb Co. has a low Put/Call ratio of 0.40 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Bristol-Myers Squibb Co. is ranked 1011.
Estimated EPS Growth
Bristol-Myers Squibb Co. rank is 1089
Historic EPS Growth
Bristol-Myers Squibb Co. rank is 1452
Estimated Revenue Growth
Bristol-Myers Squibb Co. rank is 1991
10 Day Gain
Bristol-Myers Squibb Co. rank is 2128
Debt-to-Equity
Bristol-Myers Squibb Co. rank is 2174
Up EPS Surprise
Bristol-Myers Squibb Co. beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
Missed Whisper
According to EarningsWhispers.com, Bristol-Myers Squibb Co. missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Bristol-Myers Squibb Co. is ranked 134.
Overbought RSI
The 14 Day Relative-Strength Index for Bristol-Myers Squibb Co. is 71.1. An RSI above 70 indicates the stock is overbought. Among companies with a high RSI, Bristol-Myers Squibb Co. is ranked 463.
Price-to-Book
Bristol-Myers Squibb Co. rank is 675
Price-to-Sales
Bristol-Myers Squibb Co. rank is 1057
Overbought Stochastics
Bristol-Myers Squibb Co. rank is 1068
Negative Revenue Growth
Bristol-Myers Squibb Co. rank is 1276
Negative Cash Growth
Bristol-Myers Squibb Co. rank is 1451
High vPut/Call
Bristol-Myers Squibb Co. has a high Put/Call ratio of 0.76 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Bristol-Myers Squibb Co. is ranked 1741.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.